Blagoje Murganic (Blagoje Murganić)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Breast Cancer Cells

Estrogen Receptor

Endoplasmic Reticulum Stress

Top Venues

RSC medicinal chemistry

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Aleksandr Kazimir, Tom Götze, Peter Lönnecke, Blagoje Murganic, Sanja Mijatovic, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Exploring Raloxifene-Based Metallodrugs: A Versatile Vector Combined with Platinum(II), Palladium(II) and Nickel(II) Dichlorides and Carborates against Triple-Negative Breast Cancer. ChemMedChem 19 (14) (2024)
Aleksandr Kazimir, Tom Götze, Blagoje Murganic, Sanja Mijatovic, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Bipyraloxifene - a modified raloxifene vector against triple-negative breast cancer. RSC medicinal chemistry 15 (6) (2024)
Aleksandr Kazimir, Tom Götze, Peter Lönnecke, Blagoje Murganic, Sanja Mijatovic, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Exploring Raloxifene-Based Metallodrugs: A Versatile Vector Combined with Platinum(II), Palladium(II) and Nickel(II) Dichlorides and Carborates against Triple-Negative Breast Cancer. ChemMedChem (2024)
Aleksandr Kazimir, Tom Götze, Blagoje Murganic, Sanja Mijatovic, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins
Bipyraloxifene - a modified raloxifene vector against triple-negative breast cancer. RSC medicinal chemistry 15 (6) (2024)
Svetlana Paskaš, Blagoje Murganic, Robert Kuhnert, Evamarie Hey-Hawkins, Sanja Mijatović, Danijela Maksimović-Ivanić
Carborane-Based Analog of Rev-5901 Attenuates Growth of Colon Carcinoma In Vivo. Molecules (Basel, Switzerland) 27 (14) (2022)
Marta Gozzi, Blagoje Murganic, Dijana Drača, John Popp, Christian Rödl, Danijela Maksimović-Ivanić, Sanja Mijatovic, Evamarie Hey-Hawkins
Quinoline-Conjugated Ruthenacarboranes: Toward Hybrid Drugs with a Dual Mode of Action. ChemMedChem 14 (24) (2019)